Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Westin Noxa-health AB
AB
Active
Org 5591779045
Per Hörbergs Väg 3, 168 50
Bromma
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2018
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Westin Noxa-health AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
97
180
116
117
351
Staff expenses
—
−5
−19
−25
−38
EBITDA
4
38
4
−37
216
Depreciation & amort.
−0
—
—
—
−34
EBIT
4
38
4
−37
181
Net financials
—
—
—
—
—
Profit before tax
4
38
4
−37
181
Tax
−0
−2
−1
—
−30
Net profit
4
36
3
−37
151
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
64
85
103
65
248
Equity
66
99
102
65
216
Long-term debt
0
—
—
—
—
Short-term debt
2
−14
1
1
32
Total debt
2
−14
1
1
32
Financial ratios
5-year trend
EBITDA margin
61.4%
This company
15.8%
Market median
+289% vs market
2021
2025
Equity ratio
87.0%
This company
38.2%
Market median
+128% vs market
2021
2025
Return on equity
70.1%
This company
18.4%
Market median
+281% vs market
2021
2025
Net profit margin
43.1%
This company
8.1%
Market median
+432% vs market
2021
2025
Asset turnover
1.41×
This company
1.12×
Market median
+26% vs market
2021
2025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Westin Noxa-health AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network